Translate
About
Lsl Pharma Group Inc. (V:LSL) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 15 2026
LSL PHARMA GROUP INC. ANNOUNCES ITS PARTICIPATION IN THE "2026 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE"
Apr 9 2026
JUNO OTC, A WHOLLY-OWNED SUBSIDIARY OF LSL PHARMA GROUP, SIGNS BINDING TERM SHEET WITH INSTAPILL PRIVATE LIMITED TO SUPPLY PRIVATE LABEL LORATADINE 10 MG RDT IN CANADA
Feb 3 2026
LSL PHARMA GROUP GRANTS STOCK OPTIONS
Jan 28 2026
LSL PHARMA GROUP SUCCESSFULLY OBTAINED U.S. FDA CERTIFICATION FOR THE MANUFACTURING OF OPHTHALMIC OINTMENTS FOR COMMERCIALIZATION IN THE UNITED STATES
Dec 23 2025
LSL PHARMA GROUP ANNOUNCES CLOSING OF THE ACQUISITION OF JUNO OTC AND FINAL $2M CLOSING OF UPSIZED $12M OFFERING
Financials
Revenue
CA$26.8 M
Market Cap
CA$47.28 M
P/E Ratio
19.50
EPS
0.02